Form 4 for TNON Tenon Medical, Inc.
Accepted 2026-08-04 16:52:04 ET · period of report 2026-07-31 · accession 0001213900-26-085248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-04 16:52 | 2026-07-31 | TNON | Jacques Kristine M | Dir | M - OptEx | $0.00 | +10.1K | 20.9K | +95% | $0 |
| D | 2026-08-04 16:52 | 2026-07-31 | TNON | Jacques Kristine M | Dir | M - OptEx | $0.00 | -10.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-31 | M | A | 10,147 | $0.00 | 20,876 | D | — | — | (F1) Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. |
| 2 | Derivative | Restricted Stock Units | 2026-07-31 | M | D | 10,147 | $0.00 | 0 | D | — · — to — | 10,147 Common Stock | (F1) Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. (F2) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F1) Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. (F1) Represents conversion of 10,147 restricted stock units granted to the reporting person on October 13, 2025 into 10,147 shares of common stock of the Issuer on July 31, 2026. |